2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Liver Neoplasms
1
Hypoxia
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Interventions
Cisplatin
516
Radiotherapy
378
Cyclophosphamide
368
Carboplatin
359
Capecitabine
341
Paclitaxel
336
Oxaliplatin
335
Gemcitabine
323
Docetaxel
316
Fluorouracil
289
Drug Therapy
276
apatinib
247
Bevacizumab
247
camrelizumab
219
Etoposide
201
Irinotecan
181
Doxorubicin
181
Leucovorin
163
Dexamethasone
161
pembrolizumab
153
Neoadjuvant Therapy
146
sintilimab
145
Blood Specimen Collection
140
anlotinib
139
Pemetrexed
138
Cytarabine
138
toripalimab
134
Surgical Procedures, Operative
131
Radiosurgery
130
S 1 (combination)
125
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
inositol trispyrophosphate
×
Clear all
NCT02528526
2015-08-19
OXY1A
University of Zurich
Phase 1/2
Unknown
69 enrolled